Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- geopolitics
- europe
- Commodities
- investing
- gold
- technical analysis
- AI
- Crypto
- Technology
- nvidia
- ETF
- earnings
- Forex
- china
- oil
- Real Estate
- energy
- banking
- Volatility
- magnificent-7
- Alternatives
- apple
- emerging-markets
- switzerland
- tesla
- Middle East
- United Kingdom
- amazon
- assetmanagement
- russia
- microsoft
- ethereum
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
- performance
$HIMS spectacular revenue growth
Hims & Hers Health is a company that offers online consultations and treatments for sexual performance, hair regrowth, skin care, weight loss, and mental health. Learn how Hims connects you with licensed providers, delivers innovative products, and provides 24/7 support. Market Cap is $12.3 billion. Source: Investing visuals NB: This is NOT an investment recommendation
The rise in Japanese 30-year yields is getting some attention but one should not forget the sharp move higher across the entire US Treasury curve, which is probably the real elephant in the room.
I tend to agree with Tavi Costa that the US will need at some point to implement yield curve control. We should thus see Fed assets as a percentage of GD starts rising again. Maybe Bitcoin and Gold are starting to price something like this Source: Tavi Costa, Bloomberg
‼️Market concentration BUBBLE has risen once again:
The top 10 stocks' market cap share in the S&P 500 is now 37%. This is 10 percentage points above the highest point recorded during the Dot-Com Bubble. By comparison, their earnings share is 30% Source: Global Markets Investor, Goldman Sachs
Absolute explosion for D-Wave Quantum $QBTS this month.
Multiple God Candles and a New All-Time High 📈📈 Source: Barchart
Investing with intelligence
Our latest research, commentary and market outlooks

